The National Institute on Drug Abuse (NIDA) has agreed to fund a midstage clinical trial of a cocaine-addiction drug called vigabatrin, produced by Catalyst Pharmaceutical
Moderate drinking could slow the progress of rheumatoid arthritis over the course of decades — not enough to make an immediate, noticable impact but perhaps
As memories of Woodstock-era acid trips fade from memory, researchers are revisiting hallucinogenic drugs as possible treatments for addiction and mental illness, the New York
A survey of 11th- and 12th-grade students finds that 90 percent believe that their peers are more likely to drink and drive on prom night,
Canada’s healthcare system needs to better integrate addiction and mental-health treatment, which typically are treated separately and, as a result, ineffectively, according to a new
About 30 percent of nonsmokers who develop lung cancer have an unusual variant of a gene called GPC5 that may make them more vulnerable to
The first TV ad released in support of a marijuana legalization question that recently qualified for the California ballot features testimony from a former police
Almost 9 of 10 nonprofit groups believe that 2010 will be as difficult or more difficult fiscal year than 2009, according to a new survey.
A discussion on the future of menthol cigarettes will begin at the first meeting of the Food and Drug Administration’s (FDA) new Tobacco Products Scientific
Reproduction in whole or in part of this publication is strictly prohibited without prior consent. Photographic rights remain the property of Join Together and the Partnership for Drug-Free Kids. For reproduction inquiries, please e-mail email@example.com.